Follow The Filings

KEX Kirby Corporation

Industrials, filed as KIRBY CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 2 Owners
  • Max 13.2%
  • $36M
  • 1 new 1 reduce

In 2026 Q2 Davidson Kempner Capital Management opened a position in Kirby, while Alex Roepers trimmed.

Who owns this now

Largest portfolio weights among holders, up to 13.2% (Alex Roepers, Atlantic Investment Management). Not free-float ownership.

  1. Alex Roepers Reduce 13.2%
  2. Davidson Kempner Capital Mana... New 0.12%

Who owns KEX

Sorted by value, long equity only, as of 2026 Q2.

History
Alex Roepers, Atlantic Investment Management 13.2%, was 19.9% Reduce −27.4% 186,700 $25M History
Davidson Kempner Capital Management 0.12% New 0.12% 75,000 $10M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by KEX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KEX insider trades
  • None no insider bought on the open market
  • $19.1M sold by 10 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. William Matthew Woodruff VP of Public and Govt Affairs
    Sale
    $100K 678 shares at $147.37 99% of stake
    Traded May 15 Filed May 18
    ↗
  2. Christian G. O'Neil COO
    Sale
    $1.6M 11,287 shares at $145.93 100% of stake
    Traded May 15 Filed May 18
    ↗
  3. Amy D. Husted Exec VP General Counsel & Sec
    Sale
    $582K 4,000 shares at $145.43 27% of stake
    Traded May 15 Filed May 18
    ↗
  4. Ronald A Dragg Vice President and Controller
    Sale
    $250K 1,726 shares at $145.01 17% of stake
    Traded May 4 Filed May 6
    ↗
  5. Christian G. O'Neil COO
    Sale
    $1.5M 11,287 shares at $132.34 50% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  6. Raj Kumar CFO
    Sale
    $398K 3,000 shares at $132.70 40% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  7. David W Grzebinski CEO
    Sale
    $4.4M 34,152 shares at $130.05 26% of stake
    Traded Feb 24 Filed Feb 26
    ↗
  8. Amy D. Husted Exec VP General Counsel & Sec
    Sale
    $1.5M 11,667 shares at $129.33 44% of stake
    Traded Feb 20 Filed Feb 23
    ↗
  9. Barry E Davis Director
    Sale
    $1.1M 8,480 shares at $128.51 19% of stake
    Traded Feb 19 Filed Feb 23
    ↗
  10. Scott P Miller VP - CIO
    Sale
    $478K 3,960 shares at $120.68 53% of stake
    Traded Feb 10 Filed Feb 11
    ↗
  11. William Matthew Woodruff VP of Public and Govt Affairs
    Sale
    $244K 2,000 shares at $121.88 74% of stake
    Traded Feb 9 Filed Feb 11
    ↗
  12. Ronald A Dragg Vice President and Controller
    Sale
    $662K 5,429 shares at $122.00 34% of stake
    Traded Feb 4 Filed Feb 6
    ↗
  13. Christian G. O'Neil COO
    Sale
    $1.2M 11,145 shares at $111.68 43% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
    ↗
  14. Kurt A. Niemietz VP IR & Treasurer
    Sale
    $171K 1,500 shares at $114.12 61% of stake
    Traded Dec 1, 2025 Filed Dec 2, 2025
    ↗
  15. Amy D. Husted Exec VP General Counsel & Sec
    Sale
    $1.1M 10,413 shares at $107.42 47% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 27 option exercises, 17 share withholdings for taxes, and 9 stock grants.

Congress

1 member of Congress traded KEX in the last three years: 1 buy and 0 sales. 1 member listed it in 2025 annual reports.

All Congress trades
  1. Angus S. King, Jr. I-MESpouse Buy $1K–$15K Jul 21, 2025 filed Aug 18, 2025

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 5.02 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,5.02,5.07,9.01 Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $3.09B $3.27B $3.36B
Net income $222.94M $286.71M $354.57M
Net margin * 7.2% 8.8% 10.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.14B $1.07B $1.08B
Total non-current assets * $4.59B $4.78B $4.93B
Total assets $5.72B $5.85B $6.01B
Total current liabilities $675.8M $734.75M $706.52M
Total non-current liabilities $1.86B $1.76B $1.92B
Total equity $3.19B $3.35B $3.38B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $540.23M $756.49M $670.2M
Cash from investing -$413.15M -$400.13M -$352.18M
Cash from financing -$175.08M -$314.5M -$313.69M
Net change in cash -$48M $41.87M $4.33M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.